portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Changshan Biochemical Pharmaceutical’s capacity of low molecular weight heparin calcium injection will expand to 20 mln annually
 
CreateTime:2011-09-13     Source:ResearchInChina Editor:hangmei
Text Size:       
 
Changshan Biochemical Pharmaceutical (hereafter referred as CSBIO) was listed in Shenzhen Stock Exchange on 19 Aug. 2011, with registered capital of RMB110 million. Heparin Sodium BPC is the core p...
Forget password? get password
Welcome to our website.
This service is open to member only.

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

Related Reports
Global and China Stem Cell Industry Report, 2014-2017
China Human Vaccine Industry Report, 2014-2017
China Blood Product Industry Report, 2014-2017
China Animal Vaccine Industry Report, 2013-2016
China Contract Research Organization (CRO) Industry Report, 20...
2005-2010 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1